NDC 50090-2292

Vivotif

Salmonella Typhi Ty21a

Vivotif is a Oral Capsule, Coated in the Vaccine category. It is labeled and distributed by A-s Medication Solutions. The primary component is Salmonella Typhi Ty21a Live Antigen.

• Product ID: 50090-2292_166fcc5d-c223-4912-a648-89481539775d
• NDC: 50090-2292
• Product Type: Vaccine
• Proprietary Name: Vivotif
• Generic Name: Salmonella Typhi Ty21a
• Dosage Form: Capsule, Coated
• Route of Administration: ORAL
• Marketing Start Date: 1992-03-16
• Marketing Category: BLA / BLA
• Application Number: BLA103123
• Labeler Name: A-S Medication Solutions
• Substance Name: SALMONELLA TYPHI TY21A LIVE ANTIGEN
• Active Ingredient Strength: 2147483647 [CFU]/1
• Pharm Classes: Live Attenuated Salmonella Typhi Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Typhoid [CS],Vaccines, Attenuated [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 50090-2292-0

4 BLISTER PACK in 1 CARTON (50090-2292-0) > 1 CAPSULE, COATED in 1 BLISTER PACK (50090-2292-9)

• Marketing Start Date: 1992-03-16
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 50090-2292-9 [50090229209]

Vivotif CAPSULE, COATED

• Marketing Category: BLA
• Application Number: BLA103123
• Product Type: VACCINE
• Marketing Start Date: 1992-03-16

NDC 50090-2292-0 [50090229200]

Vivotif CAPSULE, COATED

• Marketing Category: BLA
• Application Number: BLA103123
• Product Type: VACCINE
• Billing Unit: EA
• Marketing Start Date: 1992-03-16

Drug Details

Active Ingredients

Ingredient	Strength
SALMONELLA TYPHI TY21A LIVE ANTIGEN	6000000000 [CFU]/1

Pharmacological Class

• Live Attenuated Salmonella Typhi Vaccine [EPC]
• Actively Acquired Immunity [PE]
• Vaccines
• Typhoid [CS]
• Vaccines
• Attenuated [CS]

NDC Crossover Matching brand name "Vivotif" or generic name "Salmonella Typhi Ty21a"

NDC	Brand Name	Generic Name
50090-2292	Vivotif	Salmonella typhi Ty21a
69401-000	Vivotif	Salmonella typhi Ty21a